The diagnostic value of DNA methylation in leukemia: A systematic review and meta-analysis

PLoS ONE

Volumn 9, Issue 5, 2014, Pages

  Jiang, Danjie ^a   Hong, Qingxiao ^a   Shen, Yusheng ^a   Xu, Yan ^a   Zhu, Huangkai ^a   Li, Yirun ^a   Xu, Chunjing ^a   Ouyang, Guifang ^b   Duan, Shiwei ^a  

^a NINGBO UNIVERSITY   (China)

^b NINGBO FIRST HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 2A; CYCLIN DEPENDENT KINASE INHIBITOR 2B; DNA;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER RISK; CDKN2A GENE; CDKN2B GENE; DIAGNOSTIC VALUE; DNA DETERMINATION; DNA METHYLATION; GENE IDENTIFICATION; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; ID4 GENE; LEUKEMIA; META ANALYSIS; PROGNOSIS; RISK ASSESSMENT; SYSTEMATIC REVIEW; GENETIC PREDISPOSITION; GENETICS;

DNA METHYLATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LEUKEMIA;

EID: 84901068571     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0096822     Document Type: Article

References (61)

1. Hsiao PC, Liu MC, Chen LM, Tsai CY, Wang YT, et al. (2008) Promoter methylation of p16 and EDNRB gene in leukemia patients in Taiwan. Chin J Physiol 51: 27-31.
2. Olme CH, Finnon R, Brown N, Kabacik S, Bouffler SD, et al. (2013) Live cell detection of chromosome 2 deletion and Sfpi1/PU1 loss in radiation-induced mouse acute myeloid leukaemia. Leuk Res 37: 1374-1382.
3. Lupo PJ, Nousome D, Kamdar KY, Okcu MF, Scheurer ME (2012) A caseparent triad assessment of folate metabolic genes and the risk of childhood acute lymphoblastic leukemia. Cancer Causes Control 23: 1797-1803.
4. Yalcin A, Serin MS, Emekdas G, Tiftik N, Aslan G, et al. (2009) Promoter methylation of P15(INK4B) gene is possibly associated with parvovirus B19 infection in adult acute leukemias. Int J Lab Hematol 31: 407-419.
5. Rushton L, Schnatter AR, Tang G, Glass DC (2014) Acute myeloid and chronic lymphoid leukaemias and exposure to low-level benzene among petroleum workers. Br J Cancer 110: 783-787.
6. Flodin U, Fredriksson M, Persson B, Hardell L, Axelson O (1986) Background radiation, electrical work, and some other exposures associated with acute myeloid leukemia in a case-referent study. Arch Environ Health 41: 77-84. (Pubitemid 16072746)
7. Balmain A, Gray J, Ponder B (2003) The genetics and genomics of cancer. Nat Genet 33 Suppl: 238-244. (Pubitemid 36278834)
8. Chen C, Liu Y, Lu C, Cross JR, Morris JPt, et al. (2013) Cancer-associated IDH2 mutants drive an acute myeloid leukemia that is susceptible to Brd4 inhibition. Genes Dev 27: 1974-1985.
9. Kanno S, Maeda N, Tomizawa A, Yomogida S, Katoh T, et al. (2012) Characterization of cells resistant to the potent histone deacetylase inhibitor spiruchostatin B (SP-B) and effect of overexpressed p21waf1/cip1 on the SP-B resistance or susceptibility of human leukemia cells. Int J Oncol 41: 862-868.
10. Issa JP, Baylin SB, Herman JG (1997) DNA methylation changes in hematologic malignancies: biologic and clinical implications. Leukemia 11 Suppl 1: S7-11.
11. Cechova H, Lassuthova P, Novakova L, Belickova M, Stemberkova R, et al. (2012) Monitoring of methylation changes in 9p21 region in patients with myelodysplastic syndromes and acute myeloid leukemia. Neoplasma 59: 168-174.
12. Qian J, Wang YL, Lin J, Yao DM, Xu WR, et al. (2009) Aberrant methylation of the death-associated protein kinase 1 (DAPK1) CpG island in chronic myeloid leukemia. Eur J Haematol 82: 119-123.
13. Deligezer U, Erten N, Akisik EE, Dalay N (2006) Methylation of the INK4A/ ARF locus in blood mononuclear cells. Ann Hematol 85: 102-107. (Pubitemid 43085305)
14. Matsushita M, Takeuchi S, Yang Y, Yoshino N, Tsukasaki K, et al. (2005) Methylation of the MLH1 gene in hematological malignancies. Oncol Rep 14: 191-194.
15. Li Y, Nagai H, Ohno T, Yuge M, Hatano S, et al. (2002) Aberrant DNA methylation of p57(KIP2) gene in the promoter region in lymphoid malignancies of B-cell phenotype. Blood 100: 2572-2577.
16. Wang XR, Kang HY, Cen J, Li YH, Wang LL, et al. (2010) [Methylation status of id4 gene promoter in patients with chronic myeloid leukemia]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 18: 1402-1404.
17. Laird PW (2003) The power and the promise of DNA methylation markers. Nat Rev Cancer 3: 253-266.
18. Jiang D, Zheng D, Wang L, Huang Y, Liu H, et al. (2013) Elevated PLA2G7 gene promoter methylation as a gender-specific marker of aging increases the risk of coronary heart disease in females. PLoS One 8: e59752.
19. Zhang LN, Liu PP, Wang L, Yuan F, Xu L, et al. (2013) Lower ADD1 gene promoter DNA methylation increases the risk of essential hypertension. PLoS One 8: e63455.
20. DerSimonian R (1996) Meta-analysis in the design and monitoring of clinical trials. Stat Med 15: 1237-1248; discussion 1249-1252.
21. Higgins JP, Thompson SG, Deeks JJ, Altman DG (2003) Measuring inconsistency in meta-analyses. BMJ 327: 557-560. (Pubitemid 37088507)
22. Bax L, Ikeda N, Fukui N, Yaju Y, Tsuruta H, et al. (2009) More than numbers: the power of graphs in meta-analysis. Am J Epidemiol 169: 249-255.
23. Zhao Y, Wang QS, Li HH, Bo J, Dou LP, et al. (2008) [Significance of id4 promoter methylation in monitoring AML patients with completely remission]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 16: 476-478.
24. Oka T, Ouchida M, Koyama M, Ogama Y, Takada S, et al. (2002) Gene silencing of the tyrosine phosphatase SHP1 gene by aberrant methylation in leukemias/lymphomas. Cancer Res 62: 6390-6394. (Pubitemid 35364092)
25. Xiao YH, Li XH, Tan T, Liang T, Yi H, et al. (2011) Identification of GLIPR1 tumor suppressor as methylation-silenced gene in acute myeloid leukemia by microarray analysis. J Cancer Res Clin Oncol 137: 1831-1840.
26. Martel V, Guerci A, Humbert JC, Gregoire MJ, Chery M, et al. (1997) De novo methylation of tumour suppressor genes CDKN2A and CDKN2B is a rare finding in B-cell chronic lymphocytic leukaemia. Br J Haematol 99: 320-324. (Pubitemid 27497561)
27. Capalbo G, Mueller-Kuller T, Koschmieder S, Klein HU, Ottmann OG, et al. (2013) Endoplasmic reticulum protein GliPR1 regulates G protein signaling and the cell cycle and is overexpressed in AML. Oncol Rep 30: 2254-2262.
28. Hatirnaz O, Ure U, Ar C, Akyerli C, Soysal T, et al. (2007) The SOCS-1 gene methylation in chronic myeloid leukemia patients. Am J Hematol 82: 729-730. (Pubitemid 47221655)
29. Gauffin F, Diffner E, Gustafsson B, Nordgren A, Wingren AG, et al. (2009) Expression of PTEN and SHP1, investigated from tissue microarrays in pediatric acute lymphoblastic, leukemia. Pediatr Hematol Oncol 26: 48-56.
30. Chen SS, Claus R, Lucas DM, Yu L, Qian J, et al. (2011) Silencing of the inhibitor of DNA binding protein 4 (ID4) contributes to the pathogenesis of mouse and human CLL. Blood 117: 862-871.
31. Shanmugam R, Gade P, Wilson-Weekes A, Sayar H, Suvannasankha A, et al. (2012) A noncanonical Flt3ITD/NF-kappaB signaling pathway represses DAPK1 in acute myeloid leukemia. Clin Cancer Res 18: 360-369.
32. Claus R, Hackanson B, Poetsch AR, Zucknick M, Sonnet M, et al. (2012) Quantitative analyses of DAPK1 methylation in AML and MDS. Int J Cancer 131: E138-142.
33. Zhao Y, Wang QS, Dou LP, Bo J, Li HH, et al. (2007) [Methylation of Id4 gene promoter in acute leukemia]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 15: 1156-1160.
34. Agirre X, Vizmanos JL, Calasanz MJ, Garcia-Delgado M, Larrayoz MJ, et al. (2003) Methylation of CpG dinucleotides and/or CCWGG motifs at the promoter of TP53 correlates with decreased gene expression in a subset of acute lymphoblastic leukemia patients. Oncogene 22: 1070-1072. (Pubitemid 36313150)
35. Chim CS, Wong SY, Pang A, Chu P, Lau JS, et al. (2005) Aberrant promoter methylation of the retinoic acid receptor alpha gene in acute promyelocytic leukemia. Leukemia 19: 2241-2246. (Pubitemid 41741620)
36. Chim CS, Wong AS, Kwong YL (2004) Epigenetic dysregulation of the Jak/ STAT pathway by frequent aberrant methylation of SHP1 but not SOCS1 in acute leukaemias. Ann Hematol 83: 527-532. (Pubitemid 39144754)
37. Liang T, Tan T, Xiao Y, Yi H, Li C, et al. (2009) [Methylation and expression of glioma pathogenesis-related protein 1 gene in acute myeloid leukemia]. Zhong Nan Da Xue Xue Bao Yi Xue Ban 34: 388-394.
38. Lin DJ, Fan RF, Liu XF (2008) [Significance of DNA methylation status of runx3 gene promoter region in acute leukemia]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 16: 263-266.
39. Wang Y, Zhu CS, Bi KH, Xu WW, Dong L, et al. (2011) [Study of WIF-1 promoter methylation with expressions of beta-catenin in acute leukemia]. Zhonghua Yi Xue Za Zhi 91: 2858-2860.
40. Scott S, Kimura T, Ichinohasama R, Bergen S, Magliocco A, et al. (2003) Microsatellite mutations of transforming growth factor-beta receptor type II and caspase-5 occur in human precursor T-cell lymphoblastic lymphomas/leukemias in vivo but are not associated with hMSH2 or hMLH1 promoter methylation. Leuk Res 27: 23-34. (Pubitemid 35449713)
41. Campo Dell'Orto M, Banelli B, Giarin E, Accordi B, Trentin L, et al. (2007) Down-regulation of DLX3 expression in MLL-AF4 childhood lymphoblastic leukemias is mediated by promoter region hypermethylation. Oncol Rep 18: 417-423.
42. Christiansen DH, Andersen MK, Pedersen-Bjergaard J (2003) Methylation of p15INK4B is common, is associated with deletion of genes on chromosome arm 7q and predicts a poor prognosis in therapy-related myelodysplasia and acute myeloid leukemia. Leukemia 17: 1813-1819. (Pubitemid 37185257)
43. Xu RR, Liu F, Cui X, Zhang XW, Wang Y (2011) [ID4 promoter methylation in acute myeloid leukemia]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 19: 582-584.
44. Qian J, Yao DM, Lin J, Chen Q, Li Y, et al. (2010) [Alteration of methylation status of death-associated protein kinase (dapk) gene promoter in patients with acute myeloid leukemia]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 18: 1390-1394.
45. Seedhouse CH, Das-Gupta EP, Russell NH (2003) Methylation of the hMLH1 promoter and its association with microsatellite instability in acute myeloid leukemia. Leukemia 17: 83-88. (Pubitemid 36175892)
46. Jost E, do ON, Wilop S, Herman JG, Osieka R, et al. (2009) Aberrant DNA methylation of the transcription factor C/EBPalpha in acute myelogenous leukemia. Leuk Res 33: 443-449.
47. Iwai M, Kiyoi H, Ozeki K, Kinoshita T, Emi N, et al. (2005) Expression and methylation status of the FHIT gene in acute myeloid leukemia and myelodysplastic syndrome. Leukemia 19: 1367-1375. (Pubitemid 41136330)
48. Wang YK, Zhou JH, Zhou SQ, Fang GA, Li YW, et al. (2011) [Promoter methylation status of hPer3 gene in AML patients and the in vitro effect of decitabine on the status]. Zhonghua Xue Ye Xue Za Zhi 32: 317-321.
49. Gao F, Li Y, Liu W, Lu XL, Li X, et al. (2006) [Studies on gene expression and the 59 CpG islands methylation status of E-cadherin in acute myeloid leukemia]. Zhonghua Xue Ye Xue Za Zhi 27: 25-27.
50. Qian J, Qian Z, Lin J, Yao DM, Chen Q, et al. (2011) Abnormal methylation of GRAF promoter Chinese patients with acute myeloid leukemia. Leuk Res 35: 783-786.
51. Benetatos L, Hatzimichael E, Dasoula A, Dranitsaris G, Tsiara S, et al. (2010) CpG methylation analysis of the MEG3 and SNRPN imprinted genes in acute myeloid leukemia and myelodysplastic syndromes. Leuk Res 34: 148-153.
52. Benetatos L, Dasoula A, Hatzimichael E, Syed N, Voukelatou M, et al. (2011) Polo-like kinase 2 (SNK/PLK2) is a novel epigenetically regulated gene in acute myeloid leukemia and myelodysplastic syndromes: genetic and epigenetic interactions. Ann Hematol 90: 1037-1045.
53. Otto N, Manukjan G, Gohring G, Hofmann W, Scherer R, et al. (2011) ICSBP promoter methylation in myelodysplastic syndromes and acute myeloid leukaemia. Leukemia 25: 1202-1207.
54. Agrawal-Singh S, Isken F, Agelopoulos K, Klein HU, Thoennissen NH, et al. (2012) Genome-wide analysis of histone H3 acetylation patterns in AML identifies PRDX2 as an epigenetically silenced tumor suppressor gene. Blood 119: 2346-2357.
55. Yao DM, Qian J, Lin J, Wang YL, Chen Q, et al. (2011) Aberrant methylation of CCAAT/enhancer binding protein zeta promoter in acute myeloid leukemia. Leuk Res 35: 957-960.
56. Wang XJ, Li J, Fu BJ, Guo LL, Zhang JH, et al. (2009) [Methylation status of JunB and CDH13 gene promoter in CD34(+)CD38(2) chronic myelogenous leukemia cells]. Zhongguo Shi Yan Xue Ye Xue Za Zhi 17: 1405-1408.
57. Pehlivan M, Sercan Z, Sercan HO (2009) sFRP1 promoter methylation is associated with persistent Philadelphia chromosome in chronic myeloid leukemia. Leuk Res 33: 1062-1067.
58. Song JJ, Liu Q, Li Y, Yang ZS, Yang L, et al. (2012) Epigenetic inactivation of PLCD1 in chronic myeloid leukemia. Int J Mol Med 30: 179-184.
59. Nakatsuka S, Takakuwa T, Tomita Y, Hoshida Y, Nishiu M, et al. (2003) Hypermethylation of death-associated protein (DAP) kinase CpG island is frequent not only in B-cell but also in T- and natural killer (NK)/T-cell malignancies. Cancer Sci 94: 87-91. (Pubitemid 36575864)
60. Dou LP, Liu JH, Wang C, Zhao Y, Wang QS, et al. (2009) [Study on the involvement of ZO-1 gene in leukemogenesis]. Zhonghua Xue Ye Xue Za Zhi 30: 473-476.
61. Deng G, Li ZQ, Zhao C, Yuan Y, Niu CC, et al. (2011) WNT5A expression is regulated by the status of its promoter methylation in leukaemia and can inhibit leukemic cell malignant proliferation. Oncol Rep 25: 367-376.